29 June 2022 · Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
29 June 2022 · Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance
29 June 2022 · Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
16 June 2022 · Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.
16 December 2019 · This document takes a risk based approach to assigning the in- use shelf life for eye drops used in UK hospitals based on the risks…